Aurigene Contract Decoded

🚨 *AURIGENE’S BIG CDMO MOVE: 20+ PRODUCTS. 18 MILLION UNITS. GLOBAL MARKETS.* Aurigene Pharmaceutical Services has secured a *long-term manufacturing & supply agreement with a global pharmaceutical company* — a development that highlights the growing strategic importance of India’s CDMO ecosystem. 🔹 *20+ products* in the initial portfolio 🔹 Includes *sterile injectables, biologics & topical products* 🔹 Potential commercial volume of *~18 million units annually* at maturity 🔹 Products targeted for *US, Europe, Canada & emerging markets* 🔹 *2–3 years* expected for technology transfer and scale-up 🔹 Commercial revenue expected from *2028* 💡 *But the bigger story is beyond the numbers.* This signals a broader transformation in Indian pharma: ➡️ From *generic manufacturing* ➡️ To *specialised CDMO capabilities* ➡️ From *short-term projects* ➡️ To *long-term commercial supply partnerships* ➡️ From *cost advantage* ➡️ To *technology + quality + regulatory expertise* 💉 *Why sterile injectables matter* Complex manufacturing demands: • Advanced infrastructure • Stringent contamination control • Robust validation • Regulatory excellence • Highly skilled technical teams 🌍 *The strategic message is clear:* Global pharma companies are increasingly looking at Indian CDMOs not merely as low-cost suppliers, but as *long-term strategic manufacturing partners.* 📈 *India’s CDMO opportunity is evolving — from outsourcing destination to global pharmaceutical manufacturing powerhouse.* The next phase of Indian pharma may not be just about *“How much can we manufacture?”* It could increasingly be about: *“How much complex, high-value and globally critical manufacturing can India own?”* 💬 *What does this mean for India’s CDMO growth story?* #Aurigene #CDMO #Pharma #PharmaceuticalIndustry #IndianPharma #PharmaManufacturing #ContractManufacturing #Biologics #SterileInjectables #PharmaInnovation #LifeSciences #GlobalPharma #DrugManufacturing #PharmaBusiness #Healthcare #IndiaPharma #CRDMO #PharmaTrends #SupplyChain #Manufacturing https://pharma.economictimes.indiatimes.co...